Synthesis, characterization, and biological activity of a new palladium(II) complex with deoxyalliin

被引:30
作者
Corbi, PP
Massabni, AC
Moreira, AG
Medrano, FJ
Jasiulionis, MG
Costa-Neto, CM
机构
[1] UNESP, Inst Quim, Dept Quim Geral & Inorgan, BR-14801970 Araraquara, SP, Brazil
[2] USP, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, Brazil
[3] LNLS, BR-13084971 Campinas, SP, Brazil
[4] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microimunoparasitol, BR-04023062 Sao Paulo, Brazil
来源
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE | 2005年 / 83卷 / 02期
关键词
palladium( II); deoxyalliin; S-allyl-L-cysteine; tumor cells; cancer;
D O I
10.1139/V05-003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Synthesis, characterization, and biological activity of a new water-soluble Pd(II)-deoxyalliin (S-allyl-L-cysteine) complex are described in this article. Elemental and thermal analysis for the complex are consistent with the formula [Pd(C6H10NO2S)(2)]. C-13 NMR, H-1 NMR, and IR spectroscopy show coordination of the ligand to Pd(II) through S and N atoms in a square planar geometry. Final residue of the thermal treatment was identified as a mixture of PdO and metallic Pd. Antiproliferative assays using aqueous solutions of the complex against HeLa and TM5 tumor cells showed a pronounced activity of the complex even at low concentrations. After incubation for 24 h, the complex induced cytotoxic effect over HeLa cells when used at concentrations higher than 0.40 mmol/L. At lower concentrations, the complex was nontoxic, indicating its action is probably due to cell cycle arrest, rather than cell death. In agreement with these results, the flow cytometric analysis indicated that after incubation for 24 h at low concentrations of the complex cells are arrested in G0/G1.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 25 条
[11]   Complexes of platinum(II) or palladium(II) with 1,10-phenanthroline and amino acids [J].
Jin, VX ;
Ranford, JD .
INORGANICA CHIMICA ACTA, 2000, 304 (01) :38-44
[12]  
Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7
[13]   Clinical development of platinum complexes in cancer therapy: an historical perspective and an update [J].
Lebwohl, D ;
Canetta, R .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) :1522-1534
[14]  
LI G, 1995, ONCOL REP, V2, P787
[16]  
NAKAMOTO K, 1997, INFRARED RAMAN SPE B, P385
[17]   Pd(II)- and Pt(II)-cimetidine complexes.: Crystal structure of trans-[Pt(N,S-cimetidine)2]Cl2•12H2O [J].
Onoa, GB ;
Moreno, V ;
Freisinger, E ;
Lippert, B .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2002, 89 (3-4) :237-247
[18]   Contribution to the SAR field of metallated and coordination complexes. Studies of the palladium and platinum derivatives with selected thiosemicarbazones as antitumoral drugs [J].
Quiroga, AG ;
Ranninger, CN .
COORDINATION CHEMISTRY REVIEWS, 2004, 248 (1-2) :119-133
[19]   Palladated and platinated complexes derived from phenylacetaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cells.: Formation of DNA interstrand cross-links by these complexes [J].
Quiroga, AG ;
Pérez, JM ;
Montero, EI ;
Masaguer, JR ;
Alonso, C ;
Navarro-Ranninger, C .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1998, 70 (02) :117-123
[20]  
RENIS HAROLD E., 1958, FOOD RES, V23, P345